S241656

· Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S241656, covering 2026-04-21 to 2026-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies [Phase 1, Phase 2]